Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts

Transl Cancer Res. 2018 Aug;7(Suppl 7):S802-S805. doi: 10.21037/tcr.2018.08.19.

Authors

Kristopher A Lyon^{1

2}, Jason H Huang^{1

2}

Affiliations

¹ Department of Neurosurgery, Baylor Scott & White Health, Baylor Scott & White Medical Center, Temple, TX, USA.
² Texas A&M University College of Medicine, Temple, TX, USA.

No abstract available

Grants and funding

R01 NS067435/NS/NINDS NIH HHS/United States